InvestorsHub Logo
Post# of 251712
Next 10
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

Re: None

Wednesday, 08/17/2022 2:19:28 PM

Wednesday, August 17, 2022 2:19:28 PM

Post# of 251712
BLUE - bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusio

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.